This inventor holds 6 USPTO granted patents, plus 1 CIPO patent. Top assignees: Kanegafuchi Kagaku Kogyo Kabushiki Kaisha, Kanegafuchi Chemical Industry Co., Ltd.. Active years: 1984-1993.
Company Filing History:
4 out of 698 
2 out of 109 
Years Active: 1984-1993
Title: Inventor Yutaka Ariki: Pioneering Hydroxystyrene Compounds
Introduction: Yutaka Ariki, a noted inventor based in Himeji, Japan, has made significant contributions to the field of chemistry through his innovative inventions. With a total of six patents to his name, Ariki has focused on developing hydroxystyrene compounds that demonstrate potential applications in various therapeutic areas, including the inhibition of tyrosine kinase activity.
Latest Patents: Among his latest innovations, Ariki has patented hydroxystyrene compounds that serve as active ingredients in antiallergic agents, 5-lipoxygenase inhibiting agents, antibacterial agents, and ultraviolet absorbers. His hydroxystyrene derivatives are represented by complex chemical formulas that indicate their diverse functional groups and potential applications. These compounds not only provide therapeutic benefits but also serve as valuable intermediates for the synthesis of various organic compounds.
Career Highlights: Yutaka Ariki has had a successful career, working with well-established companies like Kanegafuchi Kagaku Kogyo Kabushiki Kaisha and Kanegafuchi Chemical Industry Co., Ltd. His experience in these firms has undoubtedly influenced his innovative approach to developing functional chemical entities, contributing to advancements in the field.
Collaborations: Throughout his career, Ariki has collaborated with esteemed colleagues, including Ikuo Katsumi and Takayoshi Hidaka. These collaborations have likely fostered an environment for exchanging ideas and enhancing the creative process that leads to successful inventions.
Conclusion: Yutaka Ariki stands out as a dedicated inventor with a passion for developing novel chemical compounds with significant medical applications. His work reflects a commitment to innovation and a desire to contribute to the advancement of science and medicine through the development of effective therapeutic agents.